Status:
COMPLETED
Cognitive Behavioral Therapy for Pathological Gambling
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Pathological Gambling
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of the study is to evaluate a new form of counseling for pathological gambling and to see if the counseling is more effective than attending Gamblers Anonymous.
Detailed Description
Subjects will be assigned to counseling or be given a referral list of available Gamblers Anonymous meetings at the first visit based on answers to questions. Assignment to counseling or Gamblers Anon...
Eligibility Criteria
Inclusion
- Outpatient men and women age 18 to 75
- Presence of current DSM-IV pathological gambling for at least 6 months duration
- PG is the most problematic psychiatric disorder (in the patient's and clinician's opinion) and the primary reason for seeking treatment
- Minimum score of \>5 on the South Oaks Gambling Screen which reflects gambling severity consistent with pathological gambling
Exclusion
- Current clinically significant suicidality, severe depression (a score of ≥ 19 on the Hamilton Rating Scale for Depression, 17-item version)(30) or any other disorder requiring immediate intervention
- Presence of any clinical features requiring a higher level of care than outpatient treatment
- Cognitive impairment that interferes with the capacity to engage in CBT or to provide informed consent
- DSM-IV substance abuse or dependence within the past 3 months (see Screening Visit)
- Current Axis I diagnosis of bipolar disorder or psychotic disorder
- Previous treatment of CBT for PG (duration of at least 6 sessions); because CBT is not widely used for PG, a minimum of 6 treatments will be rare.
- Current use of psychotropic medications or within 2 months prior to study entry.
- Current participation in Gambler's Anonymous (GA).
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT00337753
Start Date
June 1 2006
End Date
June 1 2009
Last Update
January 5 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota Medical Center
Minneapolis, Minnesota, United States, 55454